These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7605348)

  • 1. Efficient redox cycling of nitroquinoline bioreductive drugs due to aerobic nitroreduction in Chinese hamster cells.
    Siim BG; Wilson WR
    Biochem Pharmacol; 1995 Jun; 50(1):75-82. PubMed ID: 7605348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and radiolytic reduction of 4-alkylamino-5-nitroquinoline bioreductive drugs. Relationship to hypoxia-selective cytotoxicity.
    Siim BG; Atwell GJ; Wilson WR
    Biochem Pharmacol; 1994 Oct; 48(8):1593-604. PubMed ID: 7980625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen dependence of the cytotoxicity and metabolic activation of 4-alkylamino-5-nitroquinoline bioreductive drugs.
    Siim BG; Atwell GJ; Wilson WR
    Br J Cancer; 1994 Oct; 70(4):596-603. PubMed ID: 7917903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugs.
    Siim BG; Atwell GJ; Anderson RF; Wardman P; Pullen SM; Wilson WR; Denny WA
    J Med Chem; 1997 Apr; 40(9):1381-90. PubMed ID: 9135035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does DNA targeting affect the cytotoxicity and cell uptake of basic nitroquinoline bioreductive drugs?
    Siim BG; Denny WA; Wilson WR
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):311-5. PubMed ID: 8195025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of the carcinogen 4-nitroquinoline 1-oxide with the non-protein thiols of mammalian cells.
    Varnes ME; Biaglow JE
    Cancer Res; 1979 Aug; 39(8):2960-5. PubMed ID: 110443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of AF-2 and 4NQO into multicell spheroids.
    Olive PL; Durand RE
    Environ Mutagen; 1983; 5(4):553-63. PubMed ID: 6409603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The two faces of aldehyde oxidase: Oxidative and reductive transformations of 5-nitroquinoline.
    Paragas EM; Humphreys SC; Min J; Joswig-Jones CA; Jones JP
    Biochem Pharmacol; 2017 Dec; 145():210-217. PubMed ID: 28888950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reduction of 4-nitroquinoline N-oxide and other radical-producing drugs to oxygen-reactive intermediates.
    Biaglow JE; Jacobson BE; Nygaard OF
    Cancer Res; 1977 Sep; 37(9):3306-13. PubMed ID: 406989
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicity of nitrobenzene compounds towards isolated hepatocytes: dependence on reduction potential.
    O'Brien PJ; Wong WC; Silva J; Khan S
    Xenobiotica; 1990 Sep; 20(9):945-55. PubMed ID: 2238713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine inhibition of the metabolic activation of a carcinogen, 4-nitroquinoline-1-oxide, in cultured Chinese hamster cells.
    Tsuda H; Yoshida D; Mizusaki S
    Carcinogenesis; 1984 Mar; 5(3):331-4. PubMed ID: 6200248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)butanamide (NSC 639862), a bisnitroimidazole with enhanced selectivity as a bioreductive drug.
    Moselen JW; Hay MP; Denny WA; Wilson WR
    Cancer Res; 1995 Feb; 55(3):574-80. PubMed ID: 7834627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
    Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
    J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nitroreduction on the alkylating reactivity and cytotoxicity of the 2,4-dinitrobenzamide-5-aziridine CB 1954 and the corresponding nitrogen mustard SN 23862: distinct mechanisms of bioreductive activation.
    Helsby NA; Wheeler SJ; Pruijn FB; Palmer BD; Yang S; Denny WA; Wilson WR
    Chem Res Toxicol; 2003 Apr; 16(4):469-78. PubMed ID: 12703963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of metabolism and oxidation-reduction cycling in the cytotoxicity of antitumor quinoneimines and quinonediimines.
    Powis G; Hodnett EM; Santone KS; See KL; Melder DC
    Cancer Res; 1987 May; 47(9):2363-70. PubMed ID: 3032421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox cycling of radical anion metabolites of toxic chemicals and drugs and the Marcus theory of electron transfer.
    Mason RP
    Environ Health Perspect; 1990 Jul; 87():237-43. PubMed ID: 2176587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S9-mediated metabolism of 1-nitropyrene to a mutagen in Chinese hamster ovary cells by ring-oxidation under aerobic conditions and by nitroreduction under anaerobic conditions.
    Thornton-Manning JR; Smith BA; Beland FA; Heflich RH
    Carcinogenesis; 1991 Dec; 12(12):2317-23. PubMed ID: 1747934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In cellulo monitoring of quinone reductase activity and reactive oxygen species production during the redox cycling of 1,2 and 1,4 quinones.
    Cassagnes LE; Perio P; Ferry G; Moulharat N; Antoine M; Gayon R; Boutin JA; Nepveu F; Reybier K
    Free Radic Biol Med; 2015 Dec; 89():126-34. PubMed ID: 26386287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic conversion of 6-nitroquinoline to the fluorophore 6-aminoquinoline selectively under hypoxic conditions.
    Rajapakse A; Linder C; Morrison RD; Sarkar U; Leigh ND; Barnes CL; Daniels JS; Gates KS
    Chem Res Toxicol; 2013 Apr; 26(4):555-63. PubMed ID: 23488987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.